Data Insights

Mitazalimab by Alligator Bioscience for Non-Small Cell Lung Cancer: Likelihood of Approval

Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Non-Small Cell Lung Cancer. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Mitazalimab in Non-Small Cell Lung Cancer

Data Insights

Mitazalimab by Alligator Bioscience for Melanoma: Likelihood of Approval

Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Melanoma. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - Mitazalimab in Melanoma

Data Insights

ALG.APV-527 by Alligator Bioscience for Metastatic Breast Cancer: Likelihood of Approval

ALG.APV-527 is under clinical development by Alligator Bioscience and currently in Phase II for Metastatic Breast Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - ALG.APV-527 in Metastatic Breast Cancer

Data Insights

ALG.APV-527 by Alligator Bioscience for Solid Tumor: Likelihood of Approval

ALG.APV-527 is under clinical development by Alligator Bioscience and currently in Phase II for Solid Tumor. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - ALG.APV-527 in Solid Tumor

Data Insights

Mitazalimab by Alligator Bioscience for Pancreatic Cancer: Likelihood of Approval

Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...

Data Insights

Mitazalimab by Alligator Bioscience for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval

Mitazalimab is under clinical development by Alligator Bioscience and currently in Phase I for Kidney Cancer (Renal Cell Cancer). According...